Sunitinib

Brand name: Sutent

B

Score B — Known Hepatotoxin

This drug is known or highly likely to cause idiosyncratic liver injury and has a characteristic signature.

Between 12 and 50 cases including small case series have been described in the medical literature.

Primary class Antineoplastic
Secondary class Solid tumors, Leukemia
FDA approval 2006